BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18864446)

  • 1. The treatment of a prostigmine-resistant case of myasthenia gravis with complete recovery with anterior pituitary treatment.
    SIMON SM
    Med Rec (Reading); 1948 May; 161(5):292-5. PubMed ID: 18864446
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostigmine-induced muscle weakness in myasthenia gravis patients.
    ROWLAND LP; KORENGOLD MC; JAFFE IA; BERG L; SHY GM
    Neurology; 1955 Feb; 5(2):89-99. PubMed ID: 13235984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood cholinesterase during the treatment of myasthenia by anti-cholinesterase drugs (prostigmine and mestinon)].
    VINCENT D; PLANQUES J; GERAUD J; DARDENNE P
    Therapie; 1960; 15():906-13. PubMed ID: 13781449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined prostigmine and acetylcholine in therapy of myasthenia gravis].
    ACCORNERO F
    Riv Neurol; 1954; 24(2):198-214. PubMed ID: 13195492
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of myasthenia gravis treated with hormones, clinical and experimental study].
    HALVORSEN KA; MIHALIEVIC D
    Dia Med; 1956 Aug; 28(60):1846-52. PubMed ID: 13375344
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis: report of a case with exophthalmos, without hyperthyroidism, relieved by neostigmine.
    HATCH HA
    N Engl J Med; 1952 May; 246(22):856-8. PubMed ID: 14929332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of myasthenia gravis; clinical experiences with the treatment of myasthenia gravis pseudoparalytica with pyridostigmine].
    SEIBERT P
    Dtsch Med Wochenschr; 1953 May; 78(22):805-7. PubMed ID: 13067995
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of myasthenia gravis treated with prostigmine].
    ALAMOS DE LOS RIOS F
    Rev Clin Esp; 1948 Jun; 29(5):321-5. PubMed ID: 18934203
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostigmine-responsiveness and the diagnosis of myasthenia gravis.
    ROWLAND LP
    Neurology; 1955 Sep; 5(9):612-23. PubMed ID: 13253829
    [No Abstract]   [Full Text] [Related]  

  • 10. Report of a case of myasthenia gravis.
    BRYAN FA
    J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis; the rationale of present day therapy.
    PITTS CN; LEE EH
    J Natl Med Assoc; 1952 Nov; 44(6):426-34. PubMed ID: 13000420
    [No Abstract]   [Full Text] [Related]  

  • 12. MYASTHENIA gravis.
    Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
    [No Abstract]   [Full Text] [Related]  

  • 13. Tetraethyl pyrophosphate in the myasthenia gravis.
    NOVOTA OJ
    Mo Med; 1952 Feb; 49(2):133-4. PubMed ID: 14938938
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of myasthenia gravis pseudoparalytica].
    UNTERHARNSCHEIDT F
    Nervenarzt; 1955 Jul; 26(7):275-9. PubMed ID: 13265940
    [No Abstract]   [Full Text] [Related]  

  • 15. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
    GUINENA YH; NABI SA; TAHER Y
    J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis; results of medical management.
    FERGUSON FR; HUTCHINSON EC; LIVERSEDGE LA
    Lancet; 1955 Sep; 269(6891):636-9. PubMed ID: 13252945
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of myasthenia gravis pseudoparalytica; clinical testing and therapy with BC substances (BC40, BC47, BC48 and BC 51)].
    PATEISKY K
    Wien Z Nervenheilkd Grenzgeb; 1959; 17():53-84. PubMed ID: 14430812
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myasthenia with amyotrophy, aggravated by prostigmine].
    DESCAMPS L
    Acta Neurol Psychiatr Belg; 1955 Apr; 55(4):344-50. PubMed ID: 13248493
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myasthenia gravis and enervation of the carotid sinus; presentation of two clinical cases with different number of years of evolution].
    ROJAS CM
    Vida Nueva; 1952 Jul; 70(1):29-33. PubMed ID: 13049744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of myasthenia].
    BAUER H; SCHMID O
    Dtsch Z Nervenheilkd; 1953; 169(6):427-37. PubMed ID: 13083321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.